Skip to main content
NIH funding notice PAR-25-311

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

Open. Closes November 15, 2027.

Posted
December 16, 2024
Close date
November 15, 2027
Activity codes
UG3, UH3
Institutes taking part
NICHD, ORWH

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

  1. Reissues: PAR-23-037 Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,928,930 in first-year total cost, median $1,669,596.

Most frequent study sections

  1. Special Emphasis Panel[ZHD1 DSR-C (55)]5

Most frequent institutions

  1. GEORGE WASHINGTON UNIVERSITY3
  2. RESEARCH TRIANGLE INSTITUTE2
Competing awards under PAR-25-311 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial1U01HD114633-01A1 · under PAR-23-037CLIFTON, REBECCA GERSNOVIEZGRIFFIN, LAURIE BETHROUSE, DWIGHT JSINKEY, RACHEL GTITA, ALAN THEVENET N.GEORGE WASHINGTON UNIVERSITY, DC$2,011,151ZHD1
2025Optimal Dosing of Understudied Drugs Administered to Pregnant Individuals per Standard of Care (PregDose)1U01HD118959-01 · under PAR-23-037CLIFTON, REBECCA GERSNOVIEZMETZ, TORRI DWATT, KEVIN MGEORGE WASHINGTON UNIVERSITY, DC$1,669,596ZHD1
2025Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial)1U01HD115553-01A1 · under PAR-23-037CARLO FONT, WALDEMAR A.DAS, ABHIKRESEARCH TRIANGLE INSTITUTE, NC$805,722ZHD1
2024Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery1U01HD114634-01 · under PAR-23-037BOGGESS, KIM ACLIFTON, REBECCA GERSNOVIEZTITA, ALAN THEVENET N.GEORGE WASHINGTON UNIVERSITY, DC$3,614,140ZHD1
2024A Prospective Randomized Controlled Trial to Evaluate the Impact of Treatment of Asymptomatic Bacteriuria on Low Birth Weight1U01HD115569-01 · under PAR-23-037CHISHOLM, CHRISTIAN AMCCLURE, ELIZABETH MRESEARCH TRIANGLE INSTITUTE, NC$828,321ZHD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-25-311: Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) | ScienceDex | ConductScience